Filing Details

Accession Number:
0001209191-14-009878
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-02-12 18:28:08
Reporting Period:
2014-02-10
Filing Date:
2014-02-12
Accepted Time:
2014-02-12 18:28:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1454189 Auspex Pharmaceuticals Inc. ASPX Pharmaceutical Preparations (2834) 954862842
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1436021 Panorama Capital, L.p. 1999 South Bascom Avenue
Suite 700
Campbell CA 95008
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-02-10 2,437,255 $0.00 2,437,255 No 4 C Direct
Common Stock Acquisiton 2014-02-10 333,334 $12.00 2,770,589 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series D Convertible Preferred Stock Disposition 2014-02-10 8,700,698 $0.00 1,933,488 $0.00
Common Stock Series E Convertible Preferred Stock Disposition 2014-02-10 2,266,952 $0.00 503,767 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
0 No 4 C Direct
Footnotes
  1. Automatic conversion, in connection with the Issuer's initial public offering, of preferred stock into shares of common stock. Every 4.5 shares of preferred stock converted into one share of common stock.
  2. The convertible preferred stock is convertible at any time, at the holder's election, and has no expiration date.